"One study in women taking testosterone after a hip fracture: those on testosterone had 50% less use of a walker or cane at six months."
If aging has started to feel like decline for you, this is worth your two minutes. Clip from my Lecture 1:
https://t.co/QsxjrzUyh8
"If your risk of recurrence is 2 in 100, and I improve that even 50%, that means I treat 100 women, one woman benefits, 98 was never going to have recurrence, and one doesn't benefit no matter what you do."
Lecture 1 clip. Free on YouTube:
https://t.co/QsxjrzUyh8
“No is not a complete sentence in medicine.”
If you were told no to hormones after cancer, this is the lecture I recorded for you. What estrogen, progesterone and testosterone actually do. Free, 42 minutes:
https://t.co/QsxjrzU0rA
When we are in a crisis, we go into fight or flight. Working more is fighting. It is a response to the crisis, a way of getting your family to safety.
https://t.co/soEUWsmdCy
No woman should be told she cannot have hormones after breast cancer.
CHOICES provides education and evidence review in oncology and hormone therapies. Not medical advice. No physician-patient relationship. Consult your own healthcare team.
https://t.co/2oghXkPFWO
@DrMvandenBrink Looking forward to meeting and welcoming you to this remarkable organization and the amazing people changing cancer care for all at City of Hope.
Such a well deserved honor for Dr Taparra’s pioneering work in NHPI health care disparities to be recognized and him be chosen with select others for the Obama Foundation USA Leaders program. Made my day to see the notice and anticipate more breakthrough work from Dr T!
It’s an honor to finally share I was selected to join the inaugural Leaders USA program at the @ObamaFoundation
I’m working with an incredible team of values-driven changemakers from across the US and USAPI to create local & global change
Mahalo President @BarackObama!
Sincere congratulations to JCO GO editors, reviewers and contributors for this outstanding 4.5 IF achievement! Content that is relevant, reviewed and informative. Kudos team!
I’m super happy for our global oncology journals getting their first impact factor!
@JCOGO_ASCO : 4.5
@ecancer : 1.8
Cheers to everyone working on this neglected field! #globalonc
@IshwariaMD@VivekSubbiah A fun option: make a special July 4th decoration with all the candles at your new home- Enjoy it while each person shares a memory from old home and hopes, dreams or plans for adventures in new home. Candles get used, memories and dreams get treasured & shared.. a joy for all!
@ASCOPres@ASCO@DrEricWiner Congratulations Sr Winer for a superb year and welcome Dr Schuchter! Know it will be another year of meaningful advances under your leadership.
We should be requiring summaries of results in all presentation that are for patients- how many per 100 who take the therapy benefit in what ways va standard and how many per 100 have specific side effects. Reporting % improvement vs standard or placebo is not patient centric.
For the trials presented at #asco23 and other major meetings, it’s ok to think for yourself ans ask whether the trial was really well done, rather than just join the crowd. Also BTW, the reason we have “Discussion” after every talk is to ask critical questions.
For the trials presented at #asco23 and other major meetings, it’s ok to think for yourself ans ask whether the trial was really well done, rather than just join the crowd. Also BTW, the reason we have “Discussion” after every talk is to ask critical questions.
@drdonsdizon @LindaBosserman@ASCO@NCIDirector Caught up with amazing friend and mentor, @drdondizon to review my pending PhD dissertation on sex health for women with breast ca & then catch up with our inspiring @NCIDirector, Dr Monica Bertagnolli. Love #ASCO2023 and @ConquerCancerFd